Updated: Sage reports Phase 2 failure in Huntington's disease, ends drug's development
Sage’s final hope to turn its business around has failed, leaving the future of the once high-flying company and its postpartum depression …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
